CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

Background: This study was performed to evaluate the value of inflammatory biomarkers in predicting the prognosis of early-stage (stage IA-IIB) lung adenocarcinoma. Methods: Ten inflammatory biomarkers were tested with a Luminex bead-based assay in early-stage lung adenocarcinoma patients who underw...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanwei, Sun, Beibei, Hu, Minjuan, Lou, Yuqing, Lu, Jun, Zhang, Xueyan, Wang, Huimin, Qian, Jialin, Chu, Tianqing, Han, Baohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347039/
https://www.ncbi.nlm.nih.gov/pubmed/32714866
http://dx.doi.org/10.3389/fonc.2020.01049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347039/
https://www.ncbi.nlm.nih.gov/pubmed/32714866
http://dx.doi.org/10.3389/fonc.2020.01049

Ejemplares similares